Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 1/2013

01.01.2013 | Article

Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance

verfasst von: F. Dusemund, B. Bucher, S. Meyer, R. Thomann, F. Kühn, S. Bassetti, M. Sprenger, E. Baechli, T. Sigrist, M. Schwietert, D. Amin, P. Hausfater, E. Carre, P. Schuetz, J. Gaillat, K. Regez, R. Bossart, U. Schild, B. Müller, W. C. Albrich, For the ProREAL study team

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Procalcitonin (PCT)-guided antibiotic stewardship is a successful strategy to decrease antibiotic use. We assessed if clinical judgement affected compliance with a PCT-algorithm for antibiotic prescribing in a multicenter surveillance of patients with lower respiratory tract infections (LRTI).
Initiation and duration of antibiotic therapy, adherence to a PCT algorithm and outcome were monitored in consecutive adults with LRTI who were enrolled in a prospective observational quality control. We correlated initial clinical judgment of the treating physician with algorithm compliance and assessed the influence of PCT on the final decision to initiate antibiotic therapy.
PCT levels correlated with physicians’ estimates of the likelihood of bacterial infection (p for trend <0.02). PCT influenced the post-test probability of antibiotic initiation with a greater effect in patients with non-pneumonia LRTI (e.g., for bronchitis: −23 % if PCT ≤ 0.25 μg/L and +31 % if PCT > 0.25 μg/L), in European centers (e.g., in France −22 % if PCT ≤ 0.25 μg/L and +13 % if PCT > 0.25 μg/L) and in centers, which had previous experience with the PCT-algorithm (−16 % if PCT ≤ 0.25 μg/L and +19 % if PCT > 0.25 μg/L). Algorithm non-compliance, i.e. antibiotic prescribing despite low PCT-levels, was independently predicted by the likelihood of a bacterial infection as judged by the treating physician. Compliance was significantly associated with identification of a bacterial etiology (p = 0.01).
Compliance with PCT-guided antibiotic stewardship was affected by geographically and culturally-influenced subjective clinical judgment. Initiation of antibiotic therapy was altered by PCT levels. Differential compliance with antibiotic stewardship efforts contributes to geographical differences in antibiotic prescribing habits and potentially influences antibiotic resistance rates.
Literatur
1.
Zurück zum Zitat Grill MF, Maganti RK (2011) Neurotoxic effects associated with antibiotic use: management considerations. BJCP 72(3):381–93 Grill MF, Maganti RK (2011) Neurotoxic effects associated with antibiotic use: management considerations. BJCP 72(3):381–93
2.
Zurück zum Zitat Stewardson AJ, Huttner B, Harbarth S (2011) At least it won’t hurt: the personal risks of antibiotic exposure. Curr Opin Pharmacol 11(5):446–52PubMedCrossRef Stewardson AJ, Huttner B, Harbarth S (2011) At least it won’t hurt: the personal risks of antibiotic exposure. Curr Opin Pharmacol 11(5):446–52PubMedCrossRef
3.
Zurück zum Zitat Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E (2011) Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. CID 53(1):42–8CrossRef Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E (2011) Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. CID 53(1):42–8CrossRef
4.
Zurück zum Zitat Harbarth S, Emonet S (2006) Navigating the World Wide Web in search of resources on antimicrobial resistance. CID 43(1):72–8CrossRef Harbarth S, Emonet S (2006) Navigating the World Wide Web in search of resources on antimicrobial resistance. CID 43(1):72–8CrossRef
5.
Zurück zum Zitat Van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H et al (2008) Antimicrobial drug use and resistance in Europe. EID 14(11):1722–30 Van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H et al (2008) Antimicrobial drug use and resistance in Europe. EID 14(11):1722–30
6.
Zurück zum Zitat Albrich WC, Monnet DL, Harbarth S (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. EID 10(3):514–517 Albrich WC, Monnet DL, Harbarth S (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. EID 10(3):514–517
7.
Zurück zum Zitat Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T et al (2008) Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? JID 197(8):1094–1102PubMedCrossRef Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T et al (2008) Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? JID 197(8):1094–1102PubMedCrossRef
8.
Zurück zum Zitat Nasrin D, Collignon PJ, Roberts L, Wilson EJ, Pilotto LS, Douglas RM (2002) Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 324(7328):28–30PubMedCrossRef Nasrin D, Collignon PJ, Roberts L, Wilson EJ, Pilotto LS, Douglas RM (2002) Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 324(7328):28–30PubMedCrossRef
9.
Zurück zum Zitat Carmeli Y, Troillet N, Karchmer AW, Samore MH (1999) Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Int Med 159(10):1127–1132CrossRef Carmeli Y, Troillet N, Karchmer AW, Samore MH (1999) Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Int Med 159(10):1127–1132CrossRef
10.
Zurück zum Zitat Cosgrove SE, Carmeli Y (2003) The impact of antimicrobial resistance on health and economic outcomes. CID 36(11):1433–1437CrossRef Cosgrove SE, Carmeli Y (2003) The impact of antimicrobial resistance on health and economic outcomes. CID 36(11):1433–1437CrossRef
11.
Zurück zum Zitat Cosgrove SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. CID 42(Suppl 2):S82–89CrossRef Cosgrove SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. CID 42(Suppl 2):S82–89CrossRef
12.
Zurück zum Zitat Spellberg B (2011) The antibiotic crisis: can we reverse 65 years of failed stewardship? Arch Int Med 171(12):1080–1081CrossRef Spellberg B (2011) The antibiotic crisis: can we reverse 65 years of failed stewardship? Arch Int Med 171(12):1080–1081CrossRef
13.
Zurück zum Zitat Cars O, Molstad S, Melander A (2001) Variation in antibiotic use in the European Union. Lancet 357(9271):1851–1853PubMedCrossRef Cars O, Molstad S, Melander A (2001) Variation in antibiotic use in the European Union. Lancet 357(9271):1851–1853PubMedCrossRef
14.
Zurück zum Zitat Harbarth S, Albrich W, Goldmann DA, Huebner J (2001) Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis 1(4):251–261PubMedCrossRef Harbarth S, Albrich W, Goldmann DA, Huebner J (2001) Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis 1(4):251–261PubMedCrossRef
15.
Zurück zum Zitat Finch RG, Metlay JP, Davey PG, Baker LJ, International Forum on Antibiotic Resistance (2002) Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 4(1):44–53 Finch RG, Metlay JP, Davey PG, Baker LJ, International Forum on Antibiotic Resistance (2002) Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 4(1):44–53
16.
Zurück zum Zitat Hulscher ME, Grol RP, van der Meer JW (2010) Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10(3):167–175PubMedCrossRef Hulscher ME, Grol RP, van der Meer JW (2010) Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10(3):167–175PubMedCrossRef
17.
Zurück zum Zitat Harbarth S, Albrich W, Brun-Buisson C (2002) Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. EID 8(12):1460–1467 Harbarth S, Albrich W, Brun-Buisson C (2002) Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. EID 8(12):1460–1467
18.
Zurück zum Zitat Filippini M, Masiero G, Moschetti K (2006) Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Healthpol 78(1):77–92 Filippini M, Masiero G, Moschetti K (2006) Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Healthpol 78(1):77–92
19.
Zurück zum Zitat Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363(9409) Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363(9409)
20.
Zurück zum Zitat Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. AJRCCM 174(1):84–93 Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. AJRCCM 174(1):84–93
21.
Zurück zum Zitat Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059–1066PubMedCrossRef Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059–1066PubMedCrossRef
22.
Zurück zum Zitat Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C et al (2010) Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375(9713):463–474PubMedCrossRef Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C et al (2010) Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375(9713):463–474PubMedCrossRef
23.
Zurück zum Zitat Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Burgi U, Maurer M et al (2010) Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. EJCMID 29(3):269–277CrossRef Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Burgi U, Maurer M et al (2010) Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. EJCMID 29(3):269–277CrossRef
24.
Zurück zum Zitat Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B (2010) Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 8(5):575–587PubMedCrossRef Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B (2010) Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 8(5):575–587PubMedCrossRef
25.
Zurück zum Zitat Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kuehn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life” - an international, multicenter poststudy survey (ProREAL). Arch Int Med 172(9):715–722CrossRef Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kuehn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life” - an international, multicenter poststudy survey (ProREAL). Arch Int Med 172(9):715–722CrossRef
26.
Zurück zum Zitat Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C et al (2007) Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 7:102PubMedCrossRef Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C et al (2007) Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 7:102PubMedCrossRef
27.
Zurück zum Zitat Fischer JE, Harbarth S, Agthe AG, Benn A, Ringer SA, Goldmann DA et al (2004) Quantifying uncertainty: physicians’ estimates of infection in critically ill neonates and children. CID 38(10):1383–1390CrossRef Fischer JE, Harbarth S, Agthe AG, Benn A, Ringer SA, Goldmann DA et al (2004) Quantifying uncertainty: physicians’ estimates of infection in critically ill neonates and children. CID 38(10):1383–1390CrossRef
28.
Zurück zum Zitat Bartlett JG (2011) Diagnostic tests for agents of community-acquired pneumonia. CID 52(S4):296–304CrossRef Bartlett JG (2011) Diagnostic tests for agents of community-acquired pneumonia. CID 52(S4):296–304CrossRef
29.
Zurück zum Zitat Schwartz A (2011) Medical decision making and medical education: challenges and opportunities. Perspect Biol Med 54(1):68–74PubMedCrossRef Schwartz A (2011) Medical decision making and medical education: challenges and opportunities. Perspect Biol Med 54(1):68–74PubMedCrossRef
30.
Zurück zum Zitat Gonzales R, Sande MA (2000) Uncomplicated acute bronchitis. Ann Int Med 133(12):981–991PubMed Gonzales R, Sande MA (2000) Uncomplicated acute bronchitis. Ann Int Med 133(12):981–991PubMed
31.
Zurück zum Zitat Gonzales R, Steiner JF, Sande MA (1997) Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278(11):901–904PubMedCrossRef Gonzales R, Steiner JF, Sande MA (1997) Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278(11):901–904PubMedCrossRef
32.
Zurück zum Zitat Wenzel RP, Fowler AA (2006) Clinical practice. Acute bronchitis. N Engl J Med 355(20):2125–2130PubMedCrossRef Wenzel RP, Fowler AA (2006) Clinical practice. Acute bronchitis. N Engl J Med 355(20):2125–2130PubMedCrossRef
33.
Zurück zum Zitat Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY et al (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Medicine 6(6):e1000084PubMedCrossRef Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY et al (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Medicine 6(6):e1000084PubMedCrossRef
34.
Zurück zum Zitat Huttner B, Goossens H, Verheij T et al (2010) Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. The Lancet ID 10(1):17–31CrossRef Huttner B, Goossens H, Verheij T et al (2010) Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. The Lancet ID 10(1):17–31CrossRef
35.
Zurück zum Zitat Aujesky D, McCausland JB, Whittle J, Obrosky DS, Yealy DM, Fine MJ (2009) Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. CID 49(10):e100–108CrossRef Aujesky D, McCausland JB, Whittle J, Obrosky DS, Yealy DM, Fine MJ (2009) Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. CID 49(10):e100–108CrossRef
36.
Zurück zum Zitat Grol R, Grimshaw J (1999) Evidence-based implementation of evidence-based medicine. Joint Comm J Qual Im 25(10):503–513 Grol R, Grimshaw J (1999) Evidence-based implementation of evidence-based medicine. Joint Comm J Qual Im 25(10):503–513
37.
Zurück zum Zitat Hannes K, Leys M, Vermeire E, Aertgeerts B, Buntinx F, Depoorter AM (2005) Implementing evidence-based medicine in general practice: a focus group based study. BMC Fam Pract 6:37PubMedCrossRef Hannes K, Leys M, Vermeire E, Aertgeerts B, Buntinx F, Depoorter AM (2005) Implementing evidence-based medicine in general practice: a focus group based study. BMC Fam Pract 6:37PubMedCrossRef
38.
Zurück zum Zitat Kitto S, Petrovic A, Gruen RL, Smith JA (2011) Evidence-based medicine training and implementation in surgery: the role of surgical cultures. JECP 17(4):819 Kitto S, Petrovic A, Gruen RL, Smith JA (2011) Evidence-based medicine training and implementation in surgery: the role of surgical cultures. JECP 17(4):819
39.
Zurück zum Zitat Haspel RL (2010) Implementation and assessment of a resident curriculum in evidence-based transfusion medicine. Arch Pathol Lab Med 134(7):1054–1059PubMed Haspel RL (2010) Implementation and assessment of a resident curriculum in evidence-based transfusion medicine. Arch Pathol Lab Med 134(7):1054–1059PubMed
Metadaten
Titel
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
verfasst von
F. Dusemund
B. Bucher
S. Meyer
R. Thomann
F. Kühn
S. Bassetti
M. Sprenger
E. Baechli
T. Sigrist
M. Schwietert
D. Amin
P. Hausfater
E. Carre
P. Schuetz
J. Gaillat
K. Regez
R. Bossart
U. Schild
B. Müller
W. C. Albrich
For the ProREAL study team
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 1/2013
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1713-8

Weitere Artikel der Ausgabe 1/2013

European Journal of Clinical Microbiology & Infectious Diseases 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.